You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With a new CEO and Brazilian distributor, the Finnish firm is looking at additional Latin American and Asian markets and increased support for COVID-19 sequencing.
Osang previously granted nonexclusive US distribution rights to the PCR-based test to SG Blocks and has a manufacturing arrangement for the test with Nexus Dx.
The distribution agreement covers Euformatics' OmnomicsNGS variant interpretation and OmnomicsQ quality control software products.
Namocell has partnered with the European manufacturer to distribute its cell dispensing tool in Germany and Austria.
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
The firm said that Microbix COVID-variant quality assessment products will monitor the workflow accuracy and laboratory testing performance of Seegene variant assays.
The arrangement will allow Congenica to bring its clinical decision support platform to France for the first time.
The deal covers Agena's MassArray platform for genetic variant measurement, as well as genetic testing applications and other related products.
Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA.
Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 kit adds a research test for measuring the T cell response to SARS-CoV-2 infection to GCMS' portfolio.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.